Janney Montgomery Scott
VIR icon

Janney Montgomery Scott’s Vir Biotechnology VIR Stock Holding History

Janney Montgomery Scott’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,180
Closed -$123K – 2837
2023
Q4 		$123K Buy
+12,180
New +$111K ﹤0.01% 2534

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janney Montgomery Scott's VIR Position: Q1 2024 in Review

Janney Montgomery Scott sold out of Vir Biotechnology (VIR) in Q1 2024, closing a stake of 12,180 shares — an estimated $123K sold.

Janney Montgomery Scott first reported a position in VIR in Q4 2023 and held it in 1 quarter. The position peaked at $123K in Q4 2023. 209 funds tracked by Wall St. Rank hold VIR as of Q1 2024.

  • Janney Montgomery Scott reported no remaining Vir Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 12,180 Vir Biotechnology shares in Q1 2024, an estimated $123K.
  • Janney Montgomery Scott first reported a position in Vir Biotechnology in Q4 2023 and held it in 1 quarter.
  • Janney Montgomery Scott's Vir Biotechnology position peaked at $123K in Q4 2023.
  • 209 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2024.

Based on Janney Montgomery Scott's 13F filing for Q1 2024, filed 1 May 2024.